Cargando…
Mechanisms of endothelial dysfunction in obesity-associated hypertension
Obesity is strongly associated with high blood pressure, dyslipidemia, and type 2 diabetes. These conditions synergistically increase the risk of cardiovascular events. A number of central and peripheral abnormalities can explain the development or maintenance of high blood pressure in obesity. Of g...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Medicina Tropical
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854291/ https://www.ncbi.nlm.nih.gov/pubmed/22488221 http://dx.doi.org/10.1590/S0100-879X2012007500058 |
_version_ | 1782294774894559232 |
---|---|
author | Lobato, N.S. Filgueira, F.P. Akamine, E.H. Tostes, R.C. Carvalho, M.H.C. Fortes, Z.B. |
author_facet | Lobato, N.S. Filgueira, F.P. Akamine, E.H. Tostes, R.C. Carvalho, M.H.C. Fortes, Z.B. |
author_sort | Lobato, N.S. |
collection | PubMed |
description | Obesity is strongly associated with high blood pressure, dyslipidemia, and type 2 diabetes. These conditions synergistically increase the risk of cardiovascular events. A number of central and peripheral abnormalities can explain the development or maintenance of high blood pressure in obesity. Of great interest is endothelial dysfunction, considered to be a primary risk factor in the development of hypertension. Additional mechanisms also related to endothelial dysfunction have been proposed to mediate the development of hypertension in obese individuals. These include: increase in both peripheral vasoconstriction and renal tubular sodium reabsorption, increased sympathetic activity and overactivation of both the renin-angiotensin system and the endocannabinoid system and insulin resistance. The discovery of new mechanisms regulating metabolic and vascular function and a better understanding of how vascular function can be influenced by these systems would facilitate the development of new therapies for treatment of obesity-associated hypertension. |
format | Online Article Text |
id | pubmed-3854291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Sociedade Brasileira de Medicina Tropical |
record_format | MEDLINE/PubMed |
spelling | pubmed-38542912013-12-16 Mechanisms of endothelial dysfunction in obesity-associated hypertension Lobato, N.S. Filgueira, F.P. Akamine, E.H. Tostes, R.C. Carvalho, M.H.C. Fortes, Z.B. Braz J Med Biol Res Review Obesity is strongly associated with high blood pressure, dyslipidemia, and type 2 diabetes. These conditions synergistically increase the risk of cardiovascular events. A number of central and peripheral abnormalities can explain the development or maintenance of high blood pressure in obesity. Of great interest is endothelial dysfunction, considered to be a primary risk factor in the development of hypertension. Additional mechanisms also related to endothelial dysfunction have been proposed to mediate the development of hypertension in obese individuals. These include: increase in both peripheral vasoconstriction and renal tubular sodium reabsorption, increased sympathetic activity and overactivation of both the renin-angiotensin system and the endocannabinoid system and insulin resistance. The discovery of new mechanisms regulating metabolic and vascular function and a better understanding of how vascular function can be influenced by these systems would facilitate the development of new therapies for treatment of obesity-associated hypertension. Sociedade Brasileira de Medicina Tropical 2012-04-13 /pmc/articles/PMC3854291/ /pubmed/22488221 http://dx.doi.org/10.1590/S0100-879X2012007500058 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Lobato, N.S. Filgueira, F.P. Akamine, E.H. Tostes, R.C. Carvalho, M.H.C. Fortes, Z.B. Mechanisms of endothelial dysfunction in obesity-associated hypertension |
title | Mechanisms of endothelial dysfunction in obesity-associated hypertension |
title_full | Mechanisms of endothelial dysfunction in obesity-associated hypertension |
title_fullStr | Mechanisms of endothelial dysfunction in obesity-associated hypertension |
title_full_unstemmed | Mechanisms of endothelial dysfunction in obesity-associated hypertension |
title_short | Mechanisms of endothelial dysfunction in obesity-associated hypertension |
title_sort | mechanisms of endothelial dysfunction in obesity-associated hypertension |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854291/ https://www.ncbi.nlm.nih.gov/pubmed/22488221 http://dx.doi.org/10.1590/S0100-879X2012007500058 |
work_keys_str_mv | AT lobatons mechanismsofendothelialdysfunctioninobesityassociatedhypertension AT filgueirafp mechanismsofendothelialdysfunctioninobesityassociatedhypertension AT akamineeh mechanismsofendothelialdysfunctioninobesityassociatedhypertension AT tostesrc mechanismsofendothelialdysfunctioninobesityassociatedhypertension AT carvalhomhc mechanismsofendothelialdysfunctioninobesityassociatedhypertension AT forteszb mechanismsofendothelialdysfunctioninobesityassociatedhypertension |